SCHEMBL25039097

SCHEMBL25039097

CC(C)(CCC(C)(C)c1ccc(O)cc1O)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ SHBG P04278 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ ESR1 P03372 4/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NR1I2 O75469 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MIF P14174 1/20 0.37
▸ TYR P14679 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ NFE2L2 Q16236 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17758698 0.76 TYR (0.44) MEN1KMT2AMAPTESR1ESR2
SCHEMBL10356413 0.75 ESR1 (0.42) MEN1KMT2AMAPTESR1ESR2
SCHEMBL11115405 0.73 TYR (0.49) MEN1KMT2AMAPTESR1ESR2
SCHEMBL2946516 0.72 TYR (0.49) MEN1KMT2AMAPTESR1ESR2
SCHEMBL3435872 0.72 TYR (0.47) MEN1KMT2AMAPTSHBGESR1
SCHEMBL3700326 0.71 TYR (0.40) MEN1KMT2AMAPTLMNAHTT
SCHEMBL25037508 0.71 ESR1 (0.49) MEN1KMT2AMAPTSHBGESR1
SCHEMBL70826 0.71 SHBG (0.53) MEN1KMT2AMAPTSHBGESR1
SCHEMBL11708960 0.71 TYR (0.45) MEN1KMT2AMAPTSHBGESR1
SCHEMBL4064869 0.70 ESR1 (0.56) MEN1KMT2AMAPTSHBGESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134076-A1 THERAPY FOR INHIBITION OF SINGLE-STRANDED RNA VIRUS REPLICATION Redhill Biopharma Ltd. (IL) 2023-02-15 — — EP disclosed
Send feedback